I know a lot of holders despise and malign this website (Seeking Alpha) as desperate shorters determined to bring MSB down (bearing in mind neither a website nor shorts can bring a company down), and that's fair enough - despising it - but thought I'd post it anyway. In theory, at least, all views should be open to - rational (?) discussion in an open Forum, especially, in what is soon to be an ASX Publicly Listed Company (once again).
Personally, I have no view whatsoever on the article (and currently no position in MSB), tho I have a long familiarity with the company /stock, and a longstanding personal relationship with the founder.....(but not seen him for 2-3 years now)
But some might be interested...Feel free to slam it.
Mesoblast Is Trying To Fool Investors Again
Summary
The Phase 2 program in Rheumatoid Arthritis failed.
We believe MESO performed post-hoc analysis to data-mine for positive endpoints.
In our opinion, MESO has followed this same game plan to disastrous results in its Chronic Heart Failure trial.
Short MESO for 80% downside.
Seeking Alpha (again)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |